These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 2187005)

  • 1. Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place?
    Weller M; Wiedemann P; Heimann K
    Int Ophthalmol; 1990 Mar; 14(2):105-17. PubMed ID: 2187005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative vitreoretinopathy: an overview.
    Pastor JC
    Surv Ophthalmol; 1998; 43(1):3-18. PubMed ID: 9716190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunochemical studies of epiretinal membranes using APAAP complexes: evidence for macrophage involvement in traumatic proliferative vitreoretinopathy.
    Weller M; Heimann K; Wiedemann P
    Int Ophthalmol; 1988 Jan; 11(3):181-6. PubMed ID: 2458325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proliferative vitreoretinopathy process-To heal or not to heal].
    Grisanti S; Priglinger S; Hattenbach L
    Ophthalmologe; 2021 Jan; 118(1):10-17. PubMed ID: 33326054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mononuclear phagocytes in proliferative vitreoretinopathy (PVR). A specific role of microglial cells in non-traumatic disease?
    Weller M; Esser P; Heimann K; Wiedemann P
    Eur J Ophthalmol; 1991; 1(4):161-6. PubMed ID: 1821209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lack of an effect of intraocular steroids on irradiated fibroblasts in experimental proliferative vitreoretinopathy.
    Chandler DB; Hida T; Rozakis G; Forbes VS; Machemer R
    Graefes Arch Clin Exp Ophthalmol; 1992; 230(2):188-91. PubMed ID: 1577303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenesis of vitreoretinal proliferation and traction: a working hypothesis.
    Weller M; Heimann K; Wiedemann P
    Med Hypotheses; 1990 Feb; 31(2):157-9. PubMed ID: 2325589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of mononuclear phagocytes in a human epiretinal membrane using a monoclonal anti-human macrophage antibody.
    Weller M; Heimann K; Wiedemann P
    Graefes Arch Clin Exp Ophthalmol; 1988; 226(3):252-4. PubMed ID: 3402749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The risk factors of proliferative vitreoretinopathy after operation of retinal detachment].
    Li C
    Yan Ke Xue Bao; 1992 Jun; 8(2):83-7. PubMed ID: 1299606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy.
    Kon CH; Occleston NL; Charteris D; Daniels J; Aylward GW; Khaw PT
    Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1524-9. PubMed ID: 9660504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages.
    Hui YN; Liang HC; Cai YS; Kirchhof B; Heimann K
    Graefes Arch Clin Exp Ophthalmol; 1993 Feb; 231(2):109-14. PubMed ID: 8444357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proliferative vitreoretinopathy--pathogenesis and therapy].
    Iandiev I; Bringmann A; Wiedemann P
    Klin Monbl Augenheilkd; 2010 Mar; 227(3):168-74. PubMed ID: 20234978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative vitreoretinopathy and chemotherapeutic agents.
    Peyman GA; Schulman J
    Surv Ophthalmol; 1985; 29(6):434-42. PubMed ID: 3892742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal Detachment and Proliferative Vitreoretinopathy.
    Kwon OW; Song JH; Roh MI
    Dev Ophthalmol; 2016; 55():154-62. PubMed ID: 26501375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of severe proliferative vitreoretinopathy after retinal detachment surgery. Grade B: a determining risk factor.
    Bonnet M
    Graefes Arch Clin Exp Ophthalmol; 1988; 226(3):201-5. PubMed ID: 3402740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and risk factors for proliferative vitreoretinopathy in eyes with rhegmatogenous retinal detachment but no previous vitreoretinal surgery.
    Tseng W; Cortez RT; Ramirez G; Stinnett S; Jaffe GJ
    Am J Ophthalmol; 2004 Jun; 137(6):1105-15. PubMed ID: 15183797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intraocular surgery for secondary retinal detachment in proliferative vitreoretinopathy].
    Pournaras CJ; Donati G
    Klin Monbl Augenheilkd; 1995 May; 206(5):339-42. PubMed ID: 7609381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new model of proliferative vitreoretinopathy.
    Frenzel EM; Neely KA; Walsh AW; Cameron JD; Gregerson DS
    Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2157-64. PubMed ID: 9761295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and surgical risk factors in the development of proliferative vitreoretinopathy following retinal detachment surgery: a systematic review protocol.
    Chaudhary R; Dretzke J; Scott R; Logan A; Blanch R
    Syst Rev; 2016 Jul; 5(1):107. PubMed ID: 27391963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Idiopathic proliferative vitreoretinopathy. Activation of microglial cells as the deciding factor].
    Weller M; Esser P; Heimann K; Wiedemann P
    Ophthalmologe; 1992 Oct; 89(5):387-90. PubMed ID: 1304218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.